185 related articles for article (PubMed ID: 29212276)
1. Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk.
Xiao J; Howard L; Wan J; Wiggins E; Vidal A; Cohen P; Freedland SJ
Oncotarget; 2017 Nov; 8(55):94900-94909. PubMed ID: 29212276
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities.
Ramirez-Torres A; Reagan AL; Howard LE; Wiggins E; Vidal AC; Wan J; Miller B; Freedland SJ; Cohen P
Prostate; 2022 Sep; 82(13):1248-1257. PubMed ID: 35789022
[TBL] [Abstract][Full Text] [Related]
3. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
4. Plasma mitochondrial derived peptides MOTS-c and SHLP2 positively associate with android and liver fat in people without diabetes.
Sequeira IR; Woodhead JST; Chan A; D'Souza RF; Wan J; Hollingsworth KG; Plank LD; Cohen P; Poppitt SD; Merry TL
Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129991. PubMed ID: 34419510
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profile of diet-induced obesity mice in response to humanin and small humanin-like peptide 2 treatment.
Mehta HH; Xiao J; Ramirez R; Miller B; Kim SJ; Cohen P; Yen K
Metabolomics; 2019 Jun; 15(6):88. PubMed ID: 31172328
[TBL] [Abstract][Full Text] [Related]
6. A naturally occurring variant of SHLP2 is a protective factor in Parkinson's disease.
Kim SJ; Miller B; Hartel NG; Ramirez R; Braniff RG; Leelaprachakul N; Huang A; Wang Y; Arpawong TE; Crimmins EM; Wang P; Sun X; Liu C; Levy D; Yen K; Petzinger GM; Graham NA; Jakowec MW; Cohen P
Mol Psychiatry; 2024 Feb; 29(2):505-517. PubMed ID: 38167865
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration.
Nashine S; Cohen P; Nesburn AB; Kuppermann BD; Kenney MC
Sci Rep; 2018 Oct; 8(1):15175. PubMed ID: 30310092
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons.
Kim SK; Tran LT; NamKoong C; Choi HJ; Chun HJ; Lee YH; Cheon M; Chung C; Hwang J; Lim HH; Shin DM; Choi YH; Kim KW
Nat Commun; 2023 Jul; 14(1):4321. PubMed ID: 37468558
[TBL] [Abstract][Full Text] [Related]
9. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers.
Cobb LJ; Lee C; Xiao J; Yen K; Wong RG; Nakamura HK; Mehta HH; Gao Q; Ashur C; Huffman DM; Wan J; Muzumdar R; Barzilai N; Cohen P
Aging (Albany NY); 2016 Apr; 8(4):796-809. PubMed ID: 27070352
[TBL] [Abstract][Full Text] [Related]
10. High-intensity interval exercise increases humanin, a mitochondrial encoded peptide, in the plasma and muscle of men.
Woodhead JST; D'Souza RF; Hedges CP; Wan J; Berridge MV; Cameron-Smith D; Cohen P; Hickey AJR; Mitchell CJ; Merry TL
J Appl Physiol (1985); 2020 May; 128(5):1346-1354. PubMed ID: 32271093
[TBL] [Abstract][Full Text] [Related]
11. Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities.
Maynard JP; Godwin TN; Lu J; Vidal I; Lotan TL; De Marzo AM; Joshu CE; Sfanos KS
Prostate; 2022 Dec; 82(16):1505-1519. PubMed ID: 35971807
[TBL] [Abstract][Full Text] [Related]
12. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
13. Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy naïve men across racial/ethnic groups.
Meza J; Babajide R; Saoud R; Sweis J; Abelleira J; Helenowski I; Jovanovic B; Eggener S; Miller FH; Horowitz JM; Casalino DD; Murphy AB
BMC Urol; 2022 Jul; 22(1):107. PubMed ID: 35850677
[TBL] [Abstract][Full Text] [Related]
14. Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer.
Hoge C; Verma S; Lama DJ; Bergelson I; Haj-Hamed M; Maynor S; Gaitonde K; Sidana A
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):567-572. PubMed ID: 32152436
[TBL] [Abstract][Full Text] [Related]
15. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
[TBL] [Abstract][Full Text] [Related]
16. A Trend Toward Aggressive Prostate Cancer.
Shah N; Ioffe V
Rev Urol; 2020; 22(3):102-109. PubMed ID: 33239969
[TBL] [Abstract][Full Text] [Related]
17. Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men.
Lynch SM; Sorice K; Tagai EK; Handorf EA
Cancer; 2020 Jan; 126(9):1949-1957. PubMed ID: 32012234
[TBL] [Abstract][Full Text] [Related]
18. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in Black men with prostate cancer: A literature review.
Lillard JW; Moses KA; Mahal BA; George DJ
Cancer; 2022 Nov; 128(21):3787-3795. PubMed ID: 36066378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
